Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-03-01 @ 6:02 AM
Study NCT ID:
NCT00868361
Status:
TERMINATED
Last Update Posted:
2009-09-16
First Post:
2009-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TAL-MB-100
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Siyu Liu, M.D., Ph.D.
Old Organization:
Vice President, Innovative Research and Development and Head of Global Clinical Operations
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |